Information  X 
Enter a valid email address

Realm Therapeutics PLC Ord 10P (RLM)

Date Time Source Announcement
20 Sep 2018 3:16 pm
RNS
Holding(s) in Company
  11:18 am
RNS
Form 8.5 (EPT/RI) Realm Therapeutics
19 Sep 2018 4:31 pm
RNS
Form 8 (OPD) - Realm Therapeutics plc
  11:11 am
RNS
Form 8.5 (EPT/RI) Realm Therapeutics
18 Sep 2018 11:19 am
RNS
Form 8.5 (EPT/RI) Realm Therapeutics
17 Sep 2018 7:00 am
RNS
Corporate Update and Hiring of Advisor
20 Aug 2018 11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Block listing Interim Review
15 Aug 2018 4:35 pm
RNS
Price Monitoring Extension
14 Aug 2018 7:10 am
RNS
Half-year Report
08 Aug 2018 7:00 am
RNS
Presents at Wedbush PacGrow Healthcare Conference
07 Aug 2018 7:00 am
RNS
Notice of Results
16 Jul 2018 5:33 pm
RNS
Holding(s) in Company
10 Jul 2018 7:00 am
RNS
Pre-Clinical Study in Atopic Dermatitis
04 Jul 2018 7:00 am
RNS
Instructions for Exchanging Ordinary Shares
  7:00 am
RNS
SEC registration effective NASDAQ listing approved
14 Jun 2018 10:54 am
RNS
Result of AGM
31 May 2018 7:00 am
RNS
Realm to Present at June Investor Conferences
24 May 2018 7:00 am
RNS
Enrollment complete for Phase 2 study of PR022
23 May 2018 7:00 am
RNS
Filing with US SEC to Facilitate Nasdaq Listing
21 May 2018 7:00 am
RNS
Data Presentation at IID 2018
02 May 2018 12:39 pm
RNS
Annual Financial Report Available
  7:00 am
RNS
Final Results
  7:00 am
RNS
Realm Files Registration for Nasdaq Listing of ADS
26 Apr 2018 2:32 pm
RNS
Notice of Results
12 Mar 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Clinical Update including PR013 Phase II results
08 Mar 2018 7:00 am
RNS
Presenting at Cowen Healthcare Conference
27 Feb 2018 7:00 am
RNS
Patent portfolio strengthened with USPTO allowance
20 Feb 2018 12:00 pm
RNS
Presentation at RBC Healthcare Conference
16 Feb 2018 7:00 am
RNS
Block listing Interim Review
15 Feb 2018 7:00 am
RNS
Clinical and Business Update
02 Jan 2018 7:00 am
RNS
Presents at 5th Annual Dermatology Summit
15 Dec 2017 7:00 am
RNS
Director/PDMR Shareholding
12 Dec 2017 7:00 am
RNS
First Patient Dosed in Phase 2 Study of PR013
05 Dec 2017 7:00 am
RNS
First Patient Dosed in Phase 2 Study of PR022
21 Nov 2017 7:00 am
RNS
Realm: Preclinical Data on PR022 Published
17 Nov 2017 7:00 am
RNS
Directorate Change
02 Nov 2017 7:00 am
RNS
Realm Therapeutics to Present at BIO-Europe? 2017
30 Oct 2017 7:00 am
RNS
Realm Presents Data at ACAAI Scientific Meeting
18 Oct 2017 7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Block Listing Application
17 Oct 2017 6:28 pm
RNS
Holding(s) in Company
16 Oct 2017 3:39 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Realm Therapeutics to speak at BIO Investor Forum
13 Oct 2017 2:20 pm
RNS
Holding(s) in Company
  2:17 pm
RNS
Holding(s) in Company
12 Oct 2017 5:48 pm
RNS
Holding(s) in Company
  3:07 pm
RNS
Realm Therapeutics: Completion of �19.3m Placing
  11:04 am
RNS
Holding(s) in Company
  10:58 am
RNS
Holding(s) in Company
09 Oct 2017 11:35 am
RNS
Result of General Meeting
22 Sep 2017 7:00 am
RNS
Proposed Placing to raise �19.3 million
  7:00 am
RNS
Interim Results
21 Sep 2017 6:01 pm
RNS
Proposed Placing to raise �19.3 million
  6:00 pm
RNS
Interim Results
11 Sep 2017 7:00 am
RNS
FDA Permits PR013 to Proceed to Phase II Trial
07 Sep 2017 7:00 am
RNS
Conference Presentation
18 Aug 2017 7:00 am
RNS
Block listing Interim Review
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t